| Phosphorylation of elongation factor-2 kinase differentially regulates the enzyme's stability under stress conditions. Huber-Keener K.J., Evans B.R., Ren X., Cheng Y., Zhang Y., Hait W.N., Yang J.M.
Biochem. Biophys. Res. Commun. 424:308-314(2012) · Mapped (1) |
| Cytoprotective effect of the elongation factor-2 kinase-mediated autophagy in breast cancer cells subjected to growth factor inhibition. Cheng Y., Li H., Ren X., Niu T., Hait W.N., Yang J.
PLoS ONE 5:e9715-e9715(2010) · Mapped (1) |
| A role for p53 in the regulation of extracellular matrix metalloproteinase inducer in human cancer cells. Zhu H., Evans B., O'Neill P., Ren X., Xu Z., Hait W.N., Yang J.M.
Cancer Biol. Ther. 8:1722-1728(2009) · Mapped (44) |
| Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells. Jin W., Scotto K.W., Hait W.N., Yang J.M.
Biochem. Pharmacol. 74:851-859(2007) · Mapped (9) |
| Elongation factor-2 kinase: its role in protein synthesis and autophagy. Hait W.N., Wu H., Jin S., Yang J.M.
Autophagy 2:294-296(2006) · Mapped (1) |
| Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim. Yang J.M., O'Neill P., Jin W., Foty R., Medina D.J., Xu Z., Lomas M., Arndt G.M., Tang Y., Nakada M. et al.
J. Biol. Chem. 281:9719-9727(2006) · Mapped (5) |
| Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Yang J.M., Xu Z., Wu H., Zhu H., Wu X., Hait W.N.
Mol. Cancer Res. 1:420-427(2003) · Mapped (5) |
| Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase. Ryazanov A.G., Ward M.D., Mendola C.E., Pavur K.S., Dorovkov M.V., Wiedmann M., Erdjument-Bromage H., Tempst P., Parmer T.G., Prostko C.R. et al.
Proc. Natl. Acad. Sci. U.S.A. 94:4884-4889(1997) · UniProtKB (4) · Mapped (11) |
